Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice

International Immunopharmacology

Volumn 22, Issue 2, 2014, Pages 498-504

  Gou, Si ^a   Zhu, Tao ^b   Wang, Wei ^a   Xiao, Min ^a   Wang, Xi Chen ^a   Chen, Zhong Hua ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Glucagon like peptide 1; Inflammation; Nuclear factor kappa B; Pulmonary fibrosis; Transforming growth factor beta1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIRAGLUTIDE; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC ANTIBIOTIC; COLLAGEN; DNA; GLUCAGON LIKE PEPTIDE 1; HYDROXYPROLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME INACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; LUNG FIBROSIS; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL COUNT; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; LUNG; LUNG LAVAGE; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS;

ACTINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; COLLAGEN; DNA; GLUCAGON-LIKE PEPTIDE 1; HYDROXYPROLINE; LUNG; MALE; MICE, INBRED C57BL; NF-KAPPA B; PULMONARY FIBROSIS; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84929306694     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.07.010     Document Type: Article

References (42)

1. G. Raghu Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011 Eur Respir J 37 4 2011 743 746
2. R.J. Homer, J.A. Elias, C.G. Lee, and E. Herzog Modern concepts on the role of inflammation in pulmonary fibrosis Arch Pathol Lab Med 135 6 2011 780 788
3. F. Chua, J. Gauldie, and G.J. Laurent Pulmonary fibrosis: searching for model answers Am J Respir Cell Mol Biol 33 1 2005 9 13 (Pubitemid 40961008)
4. N.W. Todd, I.G. Luzina, and S.P. Atamas Molecular and cellular mechanisms of pulmonary fibrosis Fibrogenesis Tissue Repair 5 1 2012 11
5. H.R. Kang, S.J. Cho, C.G. Lee, R.J. Homer, and J.A. Elias Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12 J Biol Chem 282 10 2007 7723 7732 (Pubitemid 47093708)
6. W.R. Coward, G. Saini, and G. Jenkins The pathogenesis of idiopathic pulmonary fibrosis Ther Adv Respir Dis 4 6 2010 367 388
7. S.L. Vyalov, G. Gabbiani, and Y. Kapanci Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis Am J Pathol 143 6 1993 1754 1765 (Pubitemid 24058278)
8. A.S. Chung, and W.J. Kao Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins J Biomed Mater Res A 89 4 2009 841 853
9. J.M. Cook-Mills, M.E. Marchese, and H. Abdala-Valencia Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants Antioxid Redox Signal 15 6 2011 1607 1638
10. J.F. Navarro-González, C. Mora-Fernández, M. Muros de Fuentes, and J. García-Pérez Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy Nat Rev Nephrol 7 6 2011 327 340
11. Q. Tong, L. Zheng, L. Lin, B. Li, D. Wang, and D. Li Hypoxia-induced mitogenic factor promotes vascular adhesion molecule-1 expression via the PI-3K/Akt-NF-kappaB signaling pathway Am J Respir Cell Mol Biol 35 4 2006 444 456 (Pubitemid 44477645)
12. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat Rev Immunol 2 10 2002 725 734
13. L.T. Krug, E. Torres-Gonzalez, Q. Qin, D. Sorescu, M. Rojas, and A. Stecenko et al. Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis Am J Pathol 177 2 2010 608 621
14. H. Cao, X. Zhou, J. Zhang, X. Huang, Y. Zhai, and X. Zhang et al. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance Toxicol Lett 3 2014 387 394
15. C.S. Marethe, C.K. Rayner, K.L. Jones, and M. Horowitz Glucagon-like peptides 1 and 2 in health and disease: a review Peptides 44C 2013 75 86
16. G. Richter, R. Göke, B. Göke, and R. Arnold Characterization of receptors for glucagon-like peptide-1(7-36)amide on rat lung membranes FEBS Lett 267 1 1990 78 80 (Pubitemid 20211705)
17. B. Ahren, and O. Schmitz GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes Horm Metab Res 36 11-12 2004 867 876 (Pubitemid 40115912)
18. Y. Hattori, T. Jojima, A. Tomizawa, H. Satoh, S. Hattori, K. Kasai, and T. Hayashi A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells Diabetologia 53 10 2010 2256 2263
19. Zhu, T., et al., Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor. Chin Med J (Engl). 125(8): p. 1457-64.
20. T. Ashcroft, J.M. Simpson, and V. Timbrell Simple method of estimating severity of pulmonary fibrosis on a numerical scale J Clin Pathol 41 4 1988 467 470 (Pubitemid 18098428)
21. J.F. Woessner Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid Arch Biochem Biophys 93 1961 440 447
22. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 4 2001 402 408 (Pubitemid 34164012)
23. T.J. Gross, and G.W. Hunninghake Idiopathic pulmonary fibrosis N Engl J Med 345 7 2001 517 525 (Pubitemid 32758505)
24. P.W. Noble Idiopathic pulmonary fibrosis: natural history and prognosis Clin Chest Med 27 1 Suppl. 1 2006 S11 S16 [v]
25. S. Sleijfer Bleomycin-induced pneumonitis Chest 120 2 2001 617 624 (Pubitemid 32881285)
26. A.J. Garber Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability Diabetes Care 34 Suppl. 2 2011 S279 S284
27. Y. Wei, and S. Mojsov Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences FEBS Lett 358 3 1995 219 224
28. P.W. Noble, and R.J. Homer Idiopathic pulmonary fibrosis: new insights into pathogenesis Clin Chest Med 25 4 2004 749 758 [vii] (Pubitemid 39556507)
29. K.O. Leslie Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis Arch Pathol Lab Med 136 6 2012 591 600
30. Hamman L, R.A., Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp. 74: p. 177-212.
31. J.G. Scadding, and K.F. Hinson Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis Thorax 22 4 1967 291 304
32. R.G. Crystal, J.D. Fulmer, W.C. Roberts, M.L. Moss, B.R. Line, and H.Y. Reynolds Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects Ann Intern Med 85 6 1976 769 788
33. N. Guo, J. Sun, H. Chen, H. Zhang, Z. Zhang, and D. Cai Liraglutide prevents diabetes progression in prediabetic OLETF rats Endocr J 60 1 2013 15 28
34. T. Kobayashi, X. Liu, F.Q. Wen, T. Kohyama, L. Shen, and Q.X. Wang et al. Smad3 mediates TGF-beta1-induced collagen gel contraction by human lung fibroblasts Biochem Biophys Res Commun 339 1 2006 290 295 (Pubitemid 41697548)
35. C.J. Scotton, and R.C. Chambers Molecular targets in pulmonary fibrosis: the myofibroblast in focus Chest 132 4 2007 1311 1321 (Pubitemid 47621009)
36. U. Bartram, and C.P. Speer The role of transforming growth factor beta in lung development and disease Chest 125 2 2004 754 765 (Pubitemid 38223659)
37. B.C. Willis, J.M. Liebler, K. Luby-Phelps, A.G. Nicholson, E.D. Crandall, and R.M. du Bois et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis Am J Pathol 166 5 2005 1321 1332 (Pubitemid 40586504)
38. H. Liu, A.E. Dear, L.B. Kundsen, and R.W. Simpson A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules J Endocrinol 201 1 2009 59 66
39. Y.S. Lee, M.S. Park, J.S. Choung, S.S. Kim, H.H. Oh, and C.S. Choi et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes Diabetologia 55 9 2012 2456 2468
40. S. Kalayarasan, N. Sriram, and G. Sudhandiran Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta Life Sci 82 23-24 2008 1142 1153
41. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 683 (Pubitemid 26130197)
42. Zhang, X.Y., et al., Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice. Zhonghua Yi Xue Za Zhi, 2007. 87(3): p. 195-9.